Table 2 The correlations between KK-LC-1 expression and clinicopathological characteristics
From: Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer
Variables | KK-LC-1 high expression (%) | KK-LC-1 low expression (%) | P value |
|---|---|---|---|
No. of patients | 108 (22.5) | 373 (77.5) | – |
Age | Â | Â | 0.321 |
 ≤ 65 | 95 (88.0) | 340 (91.2) |  |
 > 65 | 13 (12.0) | 33 (8.8) |  |
T grade | Â | Â | 0.001 |
 1 | 29 (26.9) | 119 (31.9) |  |
 2 | 63 (58.3) | 237 (63.5) |  |
 3 | 16 (14.8) | 17 (4.6) |  |
N grade | Â | Â | 0.071 |
 0 | 51 (47.2) | 227 (60.9) |  |
 1 | 33 (30.6) | 92 (24.7) |  |
 2 | 8 (7.4) | 16 (4.3) |  |
 3 | 16 (14.8) | 38 (10.1) |  |
Menopausal status | Â | Â | 0.930 |
 Postmenopausal | 60 (55.6) | 209 (56.0) |  |
 Premenopausal | 48 (44.4) | 164 (44.0) |  |
Recurrence/distant metastasis |  |  | < 0.001 |
 Yes | 64 (59.3) | 105 (28.2) |  |
 No | 44 (40.7) | 268 (71.8) |  |
Death |  |  | < 0.001 |
 Yes | 48 (44.4) | 41 (11.0) |  |
 No | 60 (55.6) | 332 (89.0) |  |